Neuromuscular Drugs Ref

NM Pharmacology

$12.99 · Designed for iPad. Not verified for macOS.

Complete neuromuscular pharmacology MG biologics, NMJ blockers, IVIg, botulinum toxin, statin myopathy, ICU drugs and drug interactions. BNF · NICE · Evidence-based. DESCRIPTION: IMPORTANT: This app is intended for use by qualified healthcare professionals only. Always seek the advice of a qualified clinician before making any medical or prescribing decisions. Neuromuscular Drugs Reference is a comprehensive evidence-based drug reference for neuromuscular pharmacology. Built for neurologists, anaesthetists, intensivists, and allied health professionals managing patients with neuromuscular disease. MYASTHENIA GRAVIS DRUGS - Acetylcholinesterase inhibitors: pyridostigmine full dosing protocol, neostigmine IV use, propantheline for side effects, cholinergic crisis recognition (SLUDGE) - Corticosteroids: prednisolone slow titration protocol, initial worsening warning (30-50%), bone and gastric protection, IV methylprednisolone for ICI toxicity - Steroid-sparing agents: azathioprine with TPMT testing requirement, mycophenolate mofetil, ciclosporin — full monitoring table with pre-treatment tests, ongoing tests, and onset timelines - Biologics: rituximab (anti-CD20, best in anti-MuSK MG), eculizumab (NICE TA6022 approved, meningococcal vaccination protocol), efgartigimod/Vyvgart (NICE 2022, IV and SC formulations), rozanolixizumab/Rystiggo (MHRA 2023), zilucoplan/Zilbrysq (MHRA 2023, daily SC) NEUROMUSCULAR BLOCKERS - Suxamethonium: RSI dosing, hyperkalaemia mechanism in denervated muscle, full contraindication list, malignant hyperthermia trigger - Non-depolarising agents - Reversal agents: sugammadex dosing (2/4/16mg/kg), why it is preferred over neostigmine in MG, neostigmine plus glycopyrrolate protocol, train-of-four monitoring principles - Special populations: GBS, MG, renal failure, hepatic failure, burns, malignant hyperthermia, LEMS — drug choice table GBS AND CIDP DRUGS - IVIg: full dosing protocol for GBS and MG crisis, CIDP acute and maintenance dosing, start rates, brand information (Privigen, Kiovig, Flebogamma), IgA check requirement, pre-medication, AKI avoidance, side effects management table - Plasma exchange: 5-session protocol, replacement fluid choice, contraindications, complications table (hypotension, hypocalcaemia, coagulopathy) - CIDP maintenance: subcutaneous immunoglobulin (SCIg) with PATH trial evidence, Hizentra dosing, prednisolone protocol, PREDICT trial summary - Supportive drugs LAMBERT-EATON DRUGS - Amifampridine (Firdapse) - Pyridostigmine adjunct dosing in LEMS - Malignancy screen protocol - IVIg and plasma exchange in acute LEMS BOTULINUM TOXIN - All four UK licensed preparations - Six therapeutic indications with doses - Complications table: STATIN MYOPATHY - Full SAMS spectrum table - Risk factors - Rhabdomyolysis 6-step emergency protocol - SANAM (statin-associated necrotising autoimmune myopathy) - Statin re-introduction strategy ICU NEUROMUSCULAR DRUGS - NMBA indications, TOF monitoring principles, limiting duration to 24-48h - Sedation agents: - Opioids - ICUAW prevention drug strategies DRUG INTERACTIONS - Comprehensive table of drugs worsening MG - Drugs prolonging NMJ blocker duration - Safe antiemetics in MG - Antiemetics to AVOID in MG INTERACTIVE FEATURES - Drug search: 30+ searchable entries across all sections — tap result to navigate directly to the relevant section - Quiz mode: 10 clinical pharmacology questions with detailed explanations covering all 9 sections - My Notes: personal clinical notes saved during the session - Font size adjustment: A- / A+ text scaling for bedside use - 25+ tappable references including NICE TA6022, REGAIN trial, ADAPT trial, SID-GBS 2023, PATH trial, ACURASYS trial, PREEMPT trials, anti-HMGCR myopathy literature, BNF, MHRA drug safety updates DISCLAIMER This app is intended for use by qualified healthcare professionals only as a clinical decision-support and educational reference tool. It does not replace individual clinical assessment, local prescribing protocols or official prescribing information. Always consult the current BNF before prescribing.

Ratings & Reviews

  • This app hasn’t received enough ratings or reviews to display an overview.

The developer, ATIF ELNIL, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Collected

    The developer does not collect any data from this app.

    Privacy practices may vary, for example, based on the features you use or your age. Learn More

    Accessibility

    The developer has not yet indicated which accessibility features this app supports. Learn More

    Information

    Seller
    • ATIF ELNIL
    Size
    • 15.5 MB
    Category
    • Medical
    Compatibility
    Requires iOS 26.4 or later.
    • iPhone
      Requires iOS 26.4 or later.
    • iPad
      Requires iPadOS 26.4 or later.
    • Mac
      Requires macOS 26.4 or later and a Mac with Apple M1 chip or later.
    • Apple Vision
      Requires visionOS 26.4 or later.
    Languages
    • English
    Age Rating
    16+
    Copyright
    • © 2025 Dr Atif Elnil. All rights reserved.
  • Privacy Policy

    • Supports

    • Family Sharing

      Up to six family members can use this app with Family Sharing enabled.

    More by ATIF ELNIL